A study shows that high levels of negatively charged lipids can lock growth receptors into an overactive state, driving ...
KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat. In colon cancer, the second most common cause of cancer death, such mutations ...
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside ...
Exploring the intricate signaling pathways in colorectal cancer: Implications for targeted therapies
Complex mechanisms lie in the resistance to sorafenib in HCC. Not only do they include aspects of epigenetics such as circRNA-SORE, lncRNA SNHG3, and METTL3-mediated processes, but transporters like ...
Five-year outcomes with first-line (1L) nivolumab + ipilimumab + chemotherapy (N + I + C) vs C in patients (pts) with metastatic NSCLC (mNSCLC) in CheckMate 9LA. Co-occurring RNA splicing alterations ...
3d
Lung Cancer Research Foundation Grants Team Science Award Focused on Curing EGFR-Mutant Lung Cancers
The Lung Cancer Research Foundation (LCRF) announces the first recipients of its LCRF Team Science Award on Advancing Therapies Toward Curing EGFR Mutated Lung Cancers. The project, "A novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results